Home/Lung Cancer
Condition Deep-Dive

Lung Cancer

The leading cause of cancer death globally. Smoking causes ~85% of cases; radon, air pollution, and asbestos contribute. Prevention: smoking cessation, cruciferous vegetables, lycopene, vitamin D, and antioxidant nutrition.

Cancer Evidence-Based Root-Cause Focus

Last updated:

Definition

What Is Lung Cancer?

Lung cancer is the leading cause of cancer death globally, killing more people than breast, colon, and prostate cancers combined. It arises from cells lining the airways (bronchogenic carcinoma) or alveoli, with most cases driven by carcinogen-induced DNA damage to lung epithelium.

Two main histologic categories: Non-small cell lung cancer (NSCLC, ~85%, includes adenocarcinoma, squamous cell, large cell) and Small cell lung cancer (SCLC, ~15%, more aggressive, strongly smoking-related). Modern treatment is increasingly stratified by molecular markers (EGFR, ALK, ROS1, KRAS, BRAF) and PD-L1 expression.

~85% of lung cancers are caused by tobacco smoking, but ~15% occur in never-smokers, often adenocarcinoma in women, driven by radon, air pollution, asbestos, secondhand smoke, or genetic factors. Low-dose CT screening dramatically improves mortality in high-risk current/former smokers, yet uptake remains low (~6%).

๐Ÿšจ If you smoked 20+ pack-years and are age 50-80 (current or quit within 15 years), get screened with annual low-dose CT. NLST and NELSON trials showed 20-26% reduction in lung cancer mortality. This is one of the most underused preventive interventions in medicine.
Lung Cancer illustration

Major Lung Cancer Types

๐ŸŒฑ Adenocarcinoma (~40%)

Most common in never-smokers and women. Often peripheral. Targetable mutations frequent (EGFR, ALK, ROS1, KRAS). Best response to targeted therapies and immunotherapy.

๐ŸŒ— Squamous Cell (~25%)

Strongly smoking-related. Often central, near major airways. May cause hemoptysis, post-obstructive pneumonia. Limited targetable mutations; immunotherapy increasingly important.

๐ŸŒ‘ Small Cell (~15%)

Aggressive, fast-growing, strongly smoking-related. Often disseminated at diagnosis. Initially chemo/RT-responsive; immunotherapy (atezolizumab) now standard for extensive stage.

~234K1
Annual US new diagnoses
#1
Cause of US cancer deaths
~85%
Of cases attributable to smoking
~6%
Of eligible adults get LDCT screening2
Signs & Symptoms

Symptoms of Lung Cancer

Most early lung cancers are asymptomatic, found only by screening. By the time symptoms appear, disease is often advanced. Persistent symptoms in smokers warrant urgent evaluation.

๐Ÿซ Pulmonary Symptoms

๐Ÿคง

Persistent Cough

New cough lasting >3 weeks, OR change in chronic smoker's cough. May be dry or productive. Don't dismiss in smokers.

๐Ÿฉธ

Hemoptysis (Coughing Blood)

Even small streaks of blood. ALWAYS warrants evaluation. May indicate central tumor erosion. CT chest immediately.

๐Ÿ˜ฎโ€๐Ÿ’จ

Shortness of Breath

Progressive dyspnea, especially with exertion. May indicate tumor blocking airway, pleural effusion, or lymphangitic spread.

๐Ÿ˜ฃ

Chest Pain

Dull, aching pain. May worsen with deep breathing or cough. Pleural/chest wall involvement. Shoulder pain may indicate Pancoast tumor.

โš ๏ธ Systemic & Advanced

โš–๏ธ

Unexplained Weight Loss

10+ pounds without trying. Combined with respiratory symptoms in smoker, urgent CT. Often paraneoplastic.

๐Ÿ˜ด

Profound Fatigue

Disproportionate to activity. Often paraneoplastic. Combined with constitutional symptoms (weight loss, night sweats) raises concern.

๐Ÿฆด

Bone Pain (Metastases)

Persistent back, hip, or rib pain. Lung cancer commonly metastasizes to bones. Sudden severe pain may indicate pathologic fracture.

๐Ÿง 

Neurologic Symptoms (Brain Mets)

Headache, seizures, vision changes, focal weakness. Lung cancer is leading source of brain metastases. Some paraneoplastic syndromes (Lambert-Eaton, SIADH) are specific to lung cancer.

Diagnosis

How Lung Cancer Is Diagnosed

๐Ÿฉป Screening & Imaging

๐Ÿ“ก Low-Dose CT Screening

Annual LDCT for adults 50-80 with 20+ pack-year smoking history (current or quit within 15 years). Reduces lung cancer mortality by 20-26%3.

๐Ÿ“ก Diagnostic CT Chest

When symptoms present or screening finds nodule. Characterizes lesions, identifies mediastinal nodes, plans biopsy approach.

๐Ÿ“ก PET-CT

For staging, identifies metastases. Differentiates benign from malignant nodules (SUV uptake). Standard for stages I-III workup.

๐Ÿ”ฌ Biopsy

CT-guided needle biopsy, bronchoscopy (EBUS), VATS. Tissue for histology + molecular testing + PD-L1. Essential for treatment decisions.

๐Ÿงฌ Molecular & Staging

๐Ÿงฌ Molecular Testing (NSCLC)

EGFR, ALK, ROS1, BRAF, MET, RET, KRAS, NTRK, HER2, EGFR Exon 20. Required for advanced adenocarcinoma. Determines targeted therapy options.

๐Ÿฉธ PD-L1 Expression

Immunohistochemistry. Determines immunotherapy choice. High expression (โ‰ฅ50%) supports first-line pembrolizumab monotherapy4.

๐Ÿฉธ Liquid Biopsy

Blood-based circulating tumor DNA (ctDNA) testing. Useful when tissue insufficient. Monitors response and resistance mutations during treatment.

๐Ÿ“ก Brain MRI

Standard staging for stages II-IV NSCLC and all SCLC. Lung cancer is leading cause of brain metastases.

Treatment Comparison

Holistic vs. Conventional Treatment

๐ŸŒฟ HOLISTIC
๐Ÿ’Š CONVENTIONAL
๐ŸŒฟ

Holistic / Integrative Approach

For PREVENTION (most important) + SUPPORTIVE during conventional treatment + SURVIVORSHIP

Active Treatment
Holistic = SUPPORTIVE only. Conventional oncology essential for any cure.
Prevention
~85% of cases preventable via smoking cessation + radon mitigation + air quality
Survivorship
Nutrition, exercise reduce recurrence and improve quality of life
Avoid
High-dose antioxidants during chemo/RT (may reduce efficacy)7; beta-carotene supplements in smokers (increases risk); the same caution applies to older eye-health formulas, see macular degeneration

Comprehensive Prevention & Support

  • Smoking cessation, non-negotiable. Risk falls 50% within 10 years of quitting8. Even after diagnosis, quitting improves treatment response and survival.
  • Radon testing & mitigation, 2nd leading cause of lung cancer. Free/cheap home testing. Mitigation systems install easily.
  • Reduce indoor air pollution, HEPA filters, ventilation, gas stove caution, avoid wood/incense burning indoors
  • Reduce outdoor air pollution exposure, monitor AQI, exercise in cleaner air times, N95 masks when AQI poor
  • Mediterranean / cruciferous-rich diet, modest protective effect. Cooked tomatoes, leafy greens, cruciferous vegetables daily.
  • Vitamin D optimization, deficiency associated with worse prognosis
  • Avoid beta-carotene supplements in smokers5, CARET trial showed INCREASED lung cancer risk. Food sources are safe.
  • Avoid high-dose antioxidant supplements during chemo/RT, may reduce treatment efficacy. Food sources are safe.
  • During treatment: adequate protein (1-1.5g/kg), maintain weight, address nausea
  • Exercise as tolerated, reduces fatigue, improves outcomes
  • Acupuncture, for chemo-induced nausea, neuropathy
  • Mind-body practices, meditation, yoga, support groups improve quality of life
  • Pulmonary rehabilitation, for those with reduced lung function
  • Address depression, common; treat aggressively
โœ… Critical Safety Note: Lung cancer is dramatically more treatable when caught early. If you have a smoking history, ask your doctor about LDCT screening. Holistic approaches help with prevention and supportive care, they cannot replace surgery, targeted therapy, immunotherapy, or chemotherapy for active disease.
Nutritional Strategy

Diet for Lung Cancer

Mediterranean + cruciferous + adequate protein. NO beta-carotene supplements in current/former smokers. Caution with high-dose antioxidant supplements during treatment.

โœ… Prioritize:

๐Ÿฅฆ Cruciferous Vegetables Daily

Broccoli, broccoli sprouts, cauliflower, kale, Brussels sprouts. Isothiocyanates may reduce lung cancer risk in smokers and former smokers.

๐Ÿฅš Adequate Protein

1-1.5g/kg/day. Critical during treatment to maintain muscle mass. Sarcopenia worsens chemotherapy outcomes. Eggs, fish, poultry, legumes.

๐Ÿต Green Tea

EGCG has anti-cancer effects in lab studies. 2-3 cups/day. Long-term consumption associated with reduced lung cancer risk.

๐Ÿ… Lycopene from Food

Cooked tomatoes. Inverse association with lung cancer risk. Food sources only, NOT supplements during/after smoking.

๐ŸŸ Fatty Fish (2x/week)

Omega-3 may reduce cancer cachexia. Supports immune function during treatment.

โŒ Strictly Avoid:

๐Ÿšญ ALL Tobacco & Vaping

Cigarettes, cigars, pipes, e-cigarettes, vaping. Continuing to smoke after diagnosis worsens treatment response. Quitting at ANY time improves outcomes.

๐Ÿ’Š Beta-Carotene Supplements (in Smokers)

CARET and ATBC trials: INCREASED lung cancer risk and mortality in current/former smokers. Food sources are safe, supplements are not.

๐Ÿฅฉ Heavily Charred Meats

HCAs and PAHs from grilling. Reduce charring, marinate first, use indirect heat. Limit red and processed meat overall.

๐Ÿท Heavy Alcohol

Increases lung cancer risk, especially when combined with smoking. Synergistic with tobacco. Limit or abstain.

๐Ÿ’Š High-Dose Antioxidants During Chemo/RT

May reduce treatment effectiveness. Food-based antioxidants are safe; mega-dose supplements should pause during active treatment per oncologist.

Supplement Protocol

Evidence-Based Supplements

CRITICAL: Coordinate with oncology, many supplements can interfere with chemo, targeted therapy, immunotherapy. Best supportive: vitamin D, omega-3, probiotics.

SupplementMechanism & EvidenceSuggested DoseTimingNotes
Vitamin D3Deficiency strongly associated with lung cancer mortality. Anti-proliferative in lab studies.Test 25-OH-D first and set the dose with your clinician (titrate to 40 to 60 ng/mL, the Endocrine Society's preferred range)With fat mealTest baseline. Universal nutritional gap.
Omega-3 (EPA/DHA)Reduces cancer cachexia. Supports muscle preservation during chemo. Anti-inflammatory.2,000-3,000mg EPA+DHA/dayWith fat mealDiscuss with oncologist; possible interaction with some treatments.
CurcuminAnti-inflammatory, anti-proliferative in lab. May sensitize cancer to chemo (data limited in humans).500-1,500mg/day (bioavailable form)With fat mealDiscuss timing around chemo with oncologist.
Mushroom Extracts (AHCC, Maitake)Beta-glucans support immune function. May reduce chemo-induced immunosuppression.1-3g/dayEmpty stomachAHCC most studied for cancer support.
L-GlutamineReduces chemo-induced mucositis and neuropathy. Supports muscle.10-30g/day during chemoDivided dosesDiscuss with oncologist, some controversy about feeding tumors (mostly unfounded).
MelatoninAnti-tumor effects in lab; may improve chemo tolerance. Improves sleep, supports immune function.3-20mg at bedtime30 min before sleepHigher doses studied in cancer, discuss with oncologist. Melatonin is commonly sold at doses well above what is needed, and more is not better. Start at the lowest available dose. Discuss it with your prescriber if you take sedatives, anticoagulants, or immunosuppressants.
Dietary Fiber (rather than probiotic supplements)Gut microbiome composition is associated with checkpoint inhibitor response, but probiotic supplements appear to be the wrong way to act on it. In 128 melanoma patients on checkpoint blockade, probiotic supplement use was associated with lower microbiome diversity, and the best progression-free survival occurred in those with high dietary fiber and no probiotic use.6Aim for 30g+/day dietary fiber from foodWith or without foodFeed the microbiome with fiber rather than supplementing organisms. Do not start a probiotic while on immunotherapy without your oncologist's agreement. Avoid unnecessary antibiotics around immunotherapy.
NAC (N-Acetyl Cysteine)Glutathione precursor. Reduces chemo-induced toxicity. CAUTION, controversial in lung cancer.600-1,200mg/dayDivided dosesSome studies suggest may protect cancer cells. Discuss carefully with oncologist.
Next Steps

Screening Saves Lives

If you've smoked 20+ pack-years and are 50-80, annual low-dose CT screening can detect lung cancer years before symptoms. Combined with smoking cessation, modern targeted therapies and immunotherapy, lung cancer outcomes have improved dramatically. Don't delay screening, and never give up on smoking cessation, even after diagnosis.

Explore Pneumonia โ†’ Explore Asthma โ†’

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed 27 August 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.9 Nothing on this page treats lung cancer. As this page's own comparison table puts it, holistic care is supportive only and conventional oncology is essential for any cure. Two warnings matter more than anything else here. First, if you smoke or used to smoke, do not take beta-carotene supplements: two large randomized trials found they INCREASED lung cancer incidence and mortality in smokers. Second, avoid high-dose antioxidant supplements during chemotherapy or radiotherapy, which work partly through oxidative damage. Tell your oncology team about every supplement you take, and if you smoke, quitting is the single most valuable thing on this page, including after a diagnosis.

  1. SEER (National Cancer Institute) lung and bronchus cancer statistics. seer.cancer.gov. Source for annual US incidence of roughly 234,000, lung cancer as the leading cause of US cancer death, the roughly 85% attributable to smoking, and the NSCLC/SCLC and histologic splits. ↩
  2. US Preventive Services Task Force, lung cancer screening, 2021. uspreventiveservicestaskforce.org. Annual low-dose CT for adults aged 50 to 80 with a 20 pack-year history who currently smoke or quit within the past 15 years. Uptake among eligible adults remains in the region of 5 to 6%, which is why this page states it: the test exists and almost nobody eligible is getting it. ↩
  3. National Lung Screening Trial, N Engl J Med. 2011;365:395–409 (20% reduction in lung cancer mortality with low-dose CT against chest radiography) PubMed 21714641, and the NELSON trial, N Engl J Med. 2020;382:503–513 (24 to 26% reduction in men at 10 years) PubMed 31995683. ↩
  4. KEYNOTE-024: Reck M, et al. Pembrolizumab versus chemotherapy for PD-L1-positive NSCLC. N Engl J Med. 2016;375:1823–1833. PubMed 27718847. Basis for first-line pembrolizumab monotherapy at PD-L1 expression of 50% or above. Treatment selection depends on driver mutations, histology and performance status, and belongs with an oncology team. ↩
  5. On beta-carotene, the most important safety item on this page. The Beta-Carotene and Retinol Efficacy Trial (CARET), N Engl J Med. 1996, PubMed 8602180, and the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study (ATBC), N Engl J Med. 1994, both found beta-carotene supplementation increased lung cancer incidence and mortality in smokers and asbestos-exposed workers. CARET was stopped early for harm. Beta-carotene from food is not the same thing as a supplement, and the harm signal is specific to supplementation in people who smoke or have smoked. ↩
  6. Spencer CN, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374(6575):1632–1640. science.org. In 128 patients on immune checkpoint blockade, higher dietary fiber was associated with significantly improved progression-free survival, and the most marked benefit was in those with high fiber intake and no probiotic supplement use. Over 40% of patients reported taking probiotics, which was associated with lower gut microbiome diversity. Two honest caveats: this was a melanoma cohort, not lung cancer, and it is observational. The drug class and the proposed mechanism are the same, which is why it is cited here, but the effect has not been measured in lung cancer specifically. It is enough to stop recommending probiotic supplements to people on checkpoint inhibitors. ↩
  7. On high-dose antioxidants during treatment: radiotherapy and several chemotherapies act partly through oxidative damage to tumour cells, so high-dose antioxidant supplementation during treatment carries a theoretical risk of reducing efficacy. Evidence is mixed rather than settled, which is why the page says caution rather than prohibition, and why the decision belongs with the treating oncologist. A 2024 review of 24 systematic reviews found conclusions ranging from harm to no difference to benefit, always with caveats about the size and quality of the trials, PubMed 39078314. The main human signal comes from a breast cancer chemotherapy trial rather than from lung cancer, PubMed 31855498. ↩
  8. On smoking cessation after diagnosis: quitting improves treatment tolerance, reduces complications and is associated with better survival even after a lung cancer diagnosis. Risk of lung cancer death falls substantially over the years following cessation, though it does not return to never-smoker levels. ↩
  9. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic.